Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Plug

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Gaceta Sanitaria|December 5, 2012
Amenable mortality revisited: the AMIEHS studyRasmus Hoffmann, Iris Plug, Bernadette Khoshaba, et al.
Population Health Metrics|September 21, 2011
Cause-specific mortality time series analysis: a general method to detect and correct for abrupt data production changesGrégoire Rey, Albertine Aouba, Gérard Pavillon, et al.
Haematologica|June 14, 2005
Hepatitis C and health-related quality of life among patients with hemophiliaDirk Posthouwer, Iris Plug, Johanna G van der Bom, et al.
Expert Opinion on Pharmacotherapy|September 27, 2012
Treatment options for lysosomal storage disorders: developing insightsCarin M van Gelder, Audrey A M Vollebregt, Iris Plug, et al.
Journal of Inherited Metabolic Disease|April 10, 2014
Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe diseaseCarin M van Gelder, Marianne Hoogeveen-Westerveld, Marian A Kroos, et al.
Journal of Epidemiology and Community Health|September 27, 2012
Using 'amenable mortality' as indicator of healthcare effectiveness in international comparisons: results of a validation studyJohan P Mackenbach, Rasmus Hoffmann, Bernadette Khoshaba, et al.
International Journal of Public Health|August 31, 2013
Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005Rasmus Hoffmann, Iris Plug, Martin McKee, et al.
Journal of Evaluation in Clinical Practice|April 23, 2014
The timing of introduction of pharmaceutical innovations in seven European countriesRagnar Westerling, Marcus Westin, Martin McKee, et al.
Blood|November 8, 2007
Social participation of patients with hemophilia in the NetherlandsIris Plug, Marjolein Peters, Eveline P Mauser-Bunschoten, et al.
European Journal of Public Health|March 13, 2013
Innovations in medical care and mortality trends from four circulatory diseases between 1970 and 2005Rasmus Hoffmann, Iris Plug, Martin McKee, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Gaceta Sanitaria|December 5, 2012
Amenable mortality revisited: the AMIEHS studyRasmus Hoffmann, Iris Plug, Bernadette Khoshaba, et al.
Population Health Metrics|September 21, 2011
Cause-specific mortality time series analysis: a general method to detect and correct for abrupt data production changesGrégoire Rey, Albertine Aouba, Gérard Pavillon, et al.
Haematologica|June 14, 2005
Hepatitis C and health-related quality of life among patients with hemophiliaDirk Posthouwer, Iris Plug, Johanna G van der Bom, et al.
Expert Opinion on Pharmacotherapy|September 27, 2012
Treatment options for lysosomal storage disorders: developing insightsCarin M van Gelder, Audrey A M Vollebregt, Iris Plug, et al.
Journal of Inherited Metabolic Disease|April 10, 2014
Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe diseaseCarin M van Gelder, Marianne Hoogeveen-Westerveld, Marian A Kroos, et al.
Journal of Epidemiology and Community Health|September 27, 2012
Using 'amenable mortality' as indicator of healthcare effectiveness in international comparisons: results of a validation studyJohan P Mackenbach, Rasmus Hoffmann, Bernadette Khoshaba, et al.
International Journal of Public Health|August 31, 2013
Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005Rasmus Hoffmann, Iris Plug, Martin McKee, et al.
Journal of Evaluation in Clinical Practice|April 23, 2014
The timing of introduction of pharmaceutical innovations in seven European countriesRagnar Westerling, Marcus Westin, Martin McKee, et al.
Blood|November 8, 2007
Social participation of patients with hemophilia in the NetherlandsIris Plug, Marjolein Peters, Eveline P Mauser-Bunschoten, et al.
European Journal of Public Health|March 13, 2013
Innovations in medical care and mortality trends from four circulatory diseases between 1970 and 2005Rasmus Hoffmann, Iris Plug, Martin McKee, et al.
Pageof 3